Life Science News

01 July 2003 - FDA green light for 'magic bullet' radioimmunotherapy in NHL patients

Corixa & GSK to market BEXXAR® dual action therapy for non-Hodgkins lymphoma in US. "Vision of a new direction in cancer therapy"as 63% of patients..  More >>

01 July 2003 - Supply deal with a silver lining for UK woundcare firm

AMS closes exclusive deal with J&J for alginate dressings with silver fibre Silver is a safe and effective, broad-spectrum, anti-bacterial agent used in..  More >>

30 June 2003 - New, once weekly beta-interferon treatment for MS approved in Europe

Biogen - Avonex prefilled syringe approval by EMEA Treatment for patients with multiple sclerosis ’even more convenient.’ The European Agency for Evaluation..  More >>

27 June 2003 - Toronto team takes guesswork out of metabolic riddle

Tm Bioscience rolls out drug metabolism genetic test kit One of the problems frequently encountered in drug development is how to predict the behaviour of a..  More >>

27 June 2003 - €1.2m funding for biomanufacturing development in Wales

Protherics plc wins £800,000 grant from Welsh Assembly Government to help finance development of manufacturing facility Cheshire, UK based biopharma..  More >>

27 June 2003 - New treatment for Parkinson's enters Phase III

SkyePharma’s OCR formulation of GSK’s Requip begins Phase III clinical trials SkyePharma plc’s oral controlled release formulation of GlaxoSmithKline’s..  More >>

27 June 2003 - Ireland's flagship pharmaco in choppy waters

Elan Corporation seeks extension to file Annual Report to resolve GAAP issues Elan Corporation plc, based in Dublin, Ireland said yesterday that a delay in..  More >>

26 June 2003 - 6-in-1 pill could cure heart disease epidemic

Concept ’polypill’ to revolutionise treatment for over 55s, cutting heart attacks and strokes by more than 80% Medical researchers conclude in this..  More >>

26 June 2003 - Cross-border boost for Ontario firm making BEXXAR®

New radioimmunotherapy manufacturing contract for Corixa and MDS Nordion  Corixa Corporation, based in Seattle, and MDS Nordion, based in Ottawa, have..  More >>

26 June 2003 - FDA green light for Bayer's new heart failure test

Clearance for automated BNP assay to help diagnosis of heart failure Fully automated assay for B-type natriuretic peptide runs on the ADVIA Centaur®..  More >>

26 June 2003 - Controlling bad cholesterol with a daily 'cap of tea'

Clinical trial shows LDL cholesterol lowering effect of green tea extract Ever since the 1960s there have been sporadic and, at times, anecdotal reports of..  More >>

25 June 2003 - Canadian-Norwegian pair join in hunt for 'magic bullet' target cancer

Affitech and Viventia team up to find new cancer targets and killer antibodies Viventia Biotech Inc. based in Toronto is joining forces with Oslo-based..  More >>